Opposing roles for IL‐13 and IL‐13 receptor α2 in health and disease
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Interleukin (IL)‐13 is a key inducer of several type‐2 cytokine‐dependent pathologies. It regulates inflammation, mucus production, tissue remodeling, and fibrosis. Consequently, it has become an important therapeutic target for a number of debilitating illnesses, including asthma, idiopathic pulmonary fibrosis, ulcerative colitis, as well as several other diseases in which IL‐13 is believed to be overproduced. In the murine model of schistosomiasis, IL‐13 has emerged as a central mediator of chronic infection‐induced liver pathology. Although IL‐4, IL‐5, IL‐10, and IL‐13 each regulate distinct aspects of the granulomatous inflammatory response, IL‐13 was identified as the primary mediator of liver fibrosis. Thus, elucidating the mechanisms that regulate the production and function of IL‐13 has become an intensive area of research. IL‐13 signaling is mediated by the type‐2 IL‐4 receptor, which consists of the IL‐4Rα and IL‐13Rα1 chains. However, another IL‐13‐binding chain, IL‐13Rα2, appears to strongly inhibit the activity of IL‐13. Animals deficient in IL‐13Rα2 fail to downmodulate granuloma formation in the chronic phase of infection. They also develop severe IL‐13‐dependent fibrosis and portal hypertension and quickly succumb to the infection. Here, we summarize findings from the schistosomiasis model, which illustrate opposing activities for IL‐13 and IL‐13Rα2 in health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acquisition of lymphokine-producing phenotype by CD4+ T cells
Seder, R. A., & Paul, W. E. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003223 · Cited by 1,557
Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7325 · Cited by 603 · cited 9×
“Liver fibrosis decreased over 85% when WT mice were treated with sIL-13Ra2-Fc (20).”
BackgroundMethodInfluentialSelf-citationAlcoholic liver disease: New insights in pathogenesis lead to new treatments
Lieber, C. S. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80420-1 · Cited by 260 · cited 1×
“The development of fibrosis is also an important event in cirrhosis induced by alcohol, where it is characterized by fibrous scarring and islands of hepatocellular regeneration (46).”
BackgroundInterleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts
Oriente, A., Fedarko, N. S., Pacocha, S. E., Huang, S.-K., Lichtenstein, L. M., & Essayan, D. M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35380-7 · Cited by 230 · cited 1×
“IL-13 can directly stimulate collagen deposition by fibroblasts in vitro (20, 26), and in vivo-blocking studies demonstrated that IL-13 is the central fibrogenic mediator in murine schistosomiasis (7, 20).”
Background
Cited by
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Self-citationLiver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,160
Halim, T. Y. F., Steer, C. A., Mathä, L., Gold, M. J., Martinez-Gonzalez, I., McNagny, K. M., McKenzie, A. N. J., & Takei, F. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.011 · Cited by 949
Diversity and dialogue in immunity to helminths
Allen, J. E., & Maizels, R. M. (2011) · Nature reviews. Immunology · doi:10.1038/nri2992 · Cited by 831
“In mouse schistosomiasis, IL-13-mediated granulomatous inflammation to eggs lodged in the liver causes severe disease, mirroring life-threatening human hepatosplenic schistosomiasi”
BackgroundPulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Self-citation
Metadata
- Authors
- Mentink‐Kane, M. M., & Wynn, T. A.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2004-11-11
- Volume
- 202
- Issue
- 1
- Pages
- 191-202
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W1971981438
- Cited by
- 114
- References
- 4
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Opposing roles for IL‐13 and IL‐13 receptor α2 in health and disease. https://app.cochat.ai/papers/10.1111/j.0105-2896.2004.00210.x
- The paper
- Mentink‐Kane, M. M., & Wynn, T. A. (2004). Opposing roles for IL‐13 and IL‐13 receptor α2 in health and disease. Immunological Reviews. https://doi.org/10.1111/j.0105-2896.2004.00210.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.